Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence

SummaryThe annual meeting of the American Society of Medical Oncology (ASCO) was held as usual in Chicago, while the meeting focused on gastrointestinal tumors, ASCO-GI, was held in San Francisco. In particular, ASCO-GI included many phase  III trials, the data of which have the potential to change the practice in the near future for tumors of the upper gastrointestinal tract (upper-GI), including tumors of the esophagus, gastroesophageal junction, stomach, and pancreas. Interestingly, ASCO and also the European Society for Medical O ncology (ESMO) offer the virtual plenary sessions under the motto “Today’s Science Can Wait.” As more physicians and scientists become comfortable with online tools in the post-pandemic era, presenting potential practice-changing data outside of annual meetings appears feasible. Here we presen t a summary of upper-GI tumor abstracts from two major ASCO meetings including virtual plenary series.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research